Temat: "Kidney Neoplasms" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 Cases.
Autorzy :: Agaimy A; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital of Erlangen, Erlangen.
Bonert M; Department of Pathology, St. Joseph's Healthcare Hamilton.; Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON.
Naqvi A; Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON.
Wang C; Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan, Saskatoon, SK.
Trpkov K; Alberta Precision Labs and University of Calgary, Calgary, AB.
Dettmar P; Pathology Laboratory München-Nord, München.
Wintzer HO; Pathology laboratory, Asklepios Clinic Harburg, Hamburg, Germany.
Stoehr R; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital of Erlangen, Erlangen.
Hes O; Charles University and University Hospital Plzen, Plzen, Czech Republic.
Williamson SR; Department of Pathology and Laboratory Medicine, Henry Ford Health System.; Department of Pathology, Wayne State University School of Medicine, Detroit, MI.
Gibson IW; Department of Pathology, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Hartmann A; Institute of Pathology, Friedrich-Alexander-University Erlangen-Nuremberg, University Hospital of Erlangen, Erlangen.; Pokaż więcej
Źródło :: The American journal of surgical pathology [Am J Surg Pathol] 2020 Dec; Vol. 44 (12), pp. 1658-1665.
Typ publikacji :: Journal Article
MeSH Terms :: Mutation*
Biomarkers, Tumor/*genetics
Carcinoma, Renal Cell/*genetics
Carcinoma, Renal Cell/*pathology
Histiocytosis, Langerhans-Cell/*genetics
Histiocytosis, Langerhans-Cell/*pathology
Kidney Neoplasms/*genetics
Kidney Neoplasms/*pathology
Proto-Oncogene Proteins B-raf/*genetics
Adult ; Aged ; Biomarkers, Tumor/analysis ; Carcinoma, Renal Cell/chemistry ; Carcinoma, Renal Cell/surgery ; Female ; Histiocytosis, Langerhans-Cell/metabolism ; Histiocytosis, Langerhans-Cell/surgery ; Humans ; Kidney Neoplasms/chemistry ; Kidney Neoplasms/surgery ; Male ; Middle Aged ; Neoplasm Grading ; Nephrectomy ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World.
Autorzy :: Gebbia V; Oncology Section, Department Promise, University of Palermo, Palermo, Italy; .; Medical Oncology Unit, La Maddalena Clinic for Cancer, Palermo, Italy; .; GSTU Foundation, Group for the Study of Urologic Tumors, Palermo, Italy; .
Girlando A; Radiation Therapy Unit, Istituto Clinico Humanitas, Catania, Italy.
DI Grazia A; Radiation Therapy Unit, Istituto Oncologico del Mediterraneo, Catania, Italy.
Fazio I; Radiation Therapy Unit, Casa di Cura Macchiarella, Palermo, Italy.
Borsellino N; Medical Oncology Unit, Ospedale Buccheri La Ferla, Palermo, Italy.
Piazza D; GSTU Foundation, Group for the Study of Urologic Tumors, Palermo, Italy.
Serretta V; GSTU Foundation, Group for the Study of Urologic Tumors, Palermo, Italy.; Urology Unit, Policlinico, University of Palermo, Palermo, Italy.
Pergolizzi S; Dipartimento Biomorf, Università di Messina, Messina, Italy.
Pontoriero A; UO Radioterapia, Azienda Ospedaliera Policlinico G. Martino, Messina, Italy.
Firenze A; Risk Management Unit, Policlinico, University of Palermo, Palermo, Italy.
Valerio MR; Medical Oncology Unit, Policlinico, University of Palermo, Palermo, Italy.; Pokaż więcej
Źródło :: Anticancer research [Anticancer Res] 2020 Dec; Vol. 40 (12), pp. 7037-7043.
Typ publikacji :: Journal Article
MeSH Terms :: Carcinoma, Renal Cell/*drug therapy
Carcinoma, Renal Cell/*radiotherapy
Kidney Neoplasms/*drug therapy
Kidney Neoplasms/*radiotherapy
Protein Kinase Inhibitors/*therapeutic use
Adult ; Aged ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/pathology ; Disease-Free Survival ; Female ; Humans ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Metastasis ; Protein Kinase Inhibitors/pharmacology ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma.
Autorzy :: Harada H; Division of Radiation Therapy, Radiation and Proton Therapy Center, Shizuoka Cancer Center, Shizuoka, Japan.
Shikama N; Department of Radiation Oncology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Wada H; Department of Radiation Oncology, Southern TOHOKU Proton Therapy Center, Fukushima, Japan.
Uchida N; Department of Radiation Oncology, Tottori University, Tottori, Japan.
Nozaki M; Dokkyo Medical Unversity, Saitama Medical Center, Saitama, Japan.
Hayakawa K; Department of Radiology and Radiation Oncology, Kitasato University School of Medicine, Kanagawa, Japan.; Department of Radiation Oncology, NHO Disaster Medical Center, Tokyo, Japan.
Yamada K; Department of Radiation Oncology, Seirei Mikatahara General Hospital, Shizuoka, Japan.
Nagakura H; Department of Radiology, KKR Sapporo Medical Center, Hokkaido, Japan.
Ogawa H; Division of Radiation Therapy, Radiation and Proton Therapy Center, Shizuoka Cancer Center, Shizuoka, Japan.
Miyazawa K; Department of Radiation Oncology, Showa General Hospital, Tokyo, Japan.
Katagiri H; Division of Orthopedic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Nakamura N; Department of Radiation Oncology, St. Marianna University School of Medicine, Kanagawa, Japan.; Pokaż więcej
Źródło :: Japanese journal of clinical oncology [Jpn J Clin Oncol] 2021 Jan 01; Vol. 51 (1), pp. 100-105.
Typ publikacji :: Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms :: Palliative Care*
Bone Neoplasms/*drug therapy
Bone Neoplasms/*radiotherapy
Carcinoma, Renal Cell/*drug therapy
Carcinoma, Renal Cell/*radiotherapy
Kidney Neoplasms/*drug therapy
Kidney Neoplasms/*radiotherapy
Zoledronic Acid/*therapeutic use
Aged ; Aged, 80 and over ; Bone Neoplasms/pathology ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Treatment Outcome ; Zoledronic Acid/pharmacology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Current updates and future perspectives on the management of renal cell carcinoma.
Autorzy :: Singh D; Department of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad 211007, Uttar Pradesh, India. Electronic address: .; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2021 Jan 01; Vol. 264, pp. 118632. Date of Electronic Publication: 2020 Oct 25.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Mutation*
Carcinoma, Renal Cell/*diagnosis
Kidney Neoplasms/*diagnosis
Animals ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/therapy ; Carrier Proteins/metabolism ; Disease Progression ; Epigenesis, Genetic ; Hormones/metabolism ; Humans ; Immune System ; Immunosuppression ; Kidney Neoplasms/pathology ; Kidney Neoplasms/therapy ; Mice ; Microcirculation ; Molecular Targeted Therapy ; Neoplastic Stem Cells/metabolism ; Neovascularization, Pathologic/metabolism ; Risk Factors ; Signal Transduction ; TOR Serine-Threonine Kinases/metabolism ; Tumor Microenvironment ; Tumor Suppressor Proteins/metabolism ; Ubiquitin Thiolesterase/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses: Implications for Critical Clinical Decision-making During the COVID-19 Pandemic.
Autorzy :: Ginsburg KB; Department of Urology, Wayne State University, Detroit, MI. Electronic address: .
Curtis GL; Department of Urology, Wayne State University, Detroit, MI.
Patel DN; Department of Urology, University of California San Diego, San Diego, CA.
Chen WM; Department of Urology, Wayne State University, Detroit, MI.
Strother MC; Fox Chase Cancer Center, Department of Surgical Oncology, Division of Urology and Urologic Oncology, Philadelphia, PA.
Kutikov A; Fox Chase Cancer Center, Department of Surgical Oncology, Division of Urology and Urologic Oncology, Philadelphia, PA.
Derweesh IH; Department of Urology, University of California San Diego, San Diego, CA.
Cher ML; Department of Urology, Wayne State University, Detroit, MI.; Pokaż więcej
Źródło :: Urology [Urology] 2021 Jan; Vol. 147, pp. 50-56. Date of Electronic Publication: 2020 Sep 20.
Typ publikacji :: Journal Article
MeSH Terms :: Clinical Decision-Making*
COVID-19/*prevention & control
Kidney Neoplasms/*mortality
Nephrectomy/*statistics & numerical data
Time-to-Treatment/*statistics & numerical data
Aged ; COVID-19/epidemiology ; COVID-19/transmission ; Communicable Disease Control/standards ; Databases, Factual/statistics & numerical data ; Female ; Humans ; Kaplan-Meier Estimate ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Male ; Middle Aged ; Mortality/trends ; Neoplasm Staging ; Nephrectomy/standards ; Nephrectomy/trends ; Pandemics/prevention & control ; Proportional Hazards Models ; Puerto Rico/epidemiology ; Retrospective Studies ; SARS-CoV-2/pathogenicity ; Time Factors ; Time-to-Treatment/trends ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: 18F-PSMA-1007 PET/CT for Initial Staging of Renal Cell Carcinoma in an End-Stage Renal Disease Patient.
Autorzy :: Marafi F; From the Sheikh Jaber Al Ahmad Al Sabah for Nuclear Medicine and Molecular Imaging Center, Kuwait City, Kuwait.
Sasikumar A; Department of Nuclear Medicine, St Gregorios International Cancer Care Centre, Pathanamthitta, Kerala, India.
Aldaas M; From the Sheikh Jaber Al Ahmad Al Sabah for Nuclear Medicine and Molecular Imaging Center, Kuwait City, Kuwait.
Esmail A; From the Sheikh Jaber Al Ahmad Al Sabah for Nuclear Medicine and Molecular Imaging Center, Kuwait City, Kuwait.; Pokaż więcej
Źródło :: Clinical nuclear medicine [Clin Nucl Med] 2021 Jan; Vol. 46 (1), pp. e65-e67.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Oligopeptides*
Positron Emission Tomography Computed Tomography*
Carcinoma, Renal Cell/*diagnostic imaging
Carcinoma, Renal Cell/*pathology
Kidney Failure, Chronic/*complications
Kidney Neoplasms/*diagnostic imaging
Kidney Neoplasms/*pathology
Niacinamide/*analogs & derivatives
Carcinoma, Renal Cell/complications ; Female ; Fluorine Radioisotopes ; Humans ; Kidney Neoplasms/complications ; Middle Aged ; Neoplasm Staging
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Identification of Potential Biomarkers of Prognosis-Related Long Non-Coding RNA (lncRNA) in Pediatric Rhabdoid Tumor of the Kidney Based on ceRNA Networks.
Autorzy :: Wu X; Department of Pediatric Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Liu J; Department of Pediatric Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Zhu C; Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, Qingdao, Shandong, China (mainland).
Ma M; Department of Pediatric Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Chen X; Department of Pediatric Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Liu Y; Department of Pediatric Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).
Xia N; Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, Qingdao, Shandong, China (mainland).
Dong Q; Department of Pediatric Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (mainland).; Shandong Key Laboratory of Digital Medicine and Computer Assisted Surgery, Qingdao, Shandong, China (mainland).; Pokaż więcej
Źródło :: Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2020 Dec 17; Vol. 26, pp. e927725. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :: Journal Article
MeSH Terms :: Kaplan-Meier Estimate*
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/genetics
Rhabdoid Tumor*/diagnosis
Rhabdoid Tumor*/genetics
RNA, Long Noncoding/*analysis
Biomarkers, Tumor/analysis ; Child ; Databases, Genetic ; Humans ; Prognosis ; Proportional Hazards Models ; Repressor Proteins
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma.
Autorzy :: An HJ; Department of pathology, Gyeongsang National University Changwon Hospital, Changwon.; Gyeongsang National University School of Medicine.; Gyeongsang Institute of Health Science, Jinju, South Korea.
Koh HM; Department of pathology, Gyeongsang National University Changwon Hospital, Changwon.
Lee JS; Department of pathology, Gyeongsang National University Hospital.; Gyeongsang National University School of Medicine.; Gyeongsang Institute of Health Science, Jinju, South Korea.
Song DH; Department of pathology, Gyeongsang National University Changwon Hospital, Changwon.; Gyeongsang National University School of Medicine.; Gyeongsang Institute of Health Science, Jinju, South Korea.; Pokaż więcej
Źródło :: Medicine [Medicine (Baltimore)] 2020 Dec 11; Vol. 99 (50), pp. e23277.
Typ publikacji :: Journal Article
MeSH Terms :: Carcinoma, Renal Cell/*diagnosis
Kidney Neoplasms/*diagnosis
Macrophage Migration-Inhibitory Factors/*analysis
Biomarkers, Tumor/analysis ; Blotting, Western ; Carcinoma, Renal Cell/chemistry ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/pathology ; Cell Line, Tumor ; Disease-Free Survival ; Female ; Gene Knockdown Techniques ; Humans ; Kidney/chemistry ; Kidney/cytology ; Kidney/pathology ; Kidney Neoplasms/chemistry ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Polymerase Chain Reaction ; Prognosis ; Proportional Hazards Models ; Survival Analysis ; Tissue Array Analysis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Wunderlichs syndrome in patient with sporadic bilateral angiomyolipomas - case report.
Autorzy :: Shaikh H
Nechanská B; Pokaż więcej
Transliterated Title :: Wunderlichův syndrom u pacientky se sporadickými bilaterálními angiomyolipomy.
Źródło :: Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti [Rozhl Chir] 2020 Winter; Vol. 99 (12), pp. 548-551.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Angiomyolipoma*/complications
Angiomyolipoma*/diagnostic imaging
Angiomyolipoma*/surgery
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Tuberous Sclerosis*
Aged ; Humans ; Nephrectomy ; Retroperitoneal Space/diagnostic imaging
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: [Analysis of the learning curve in laparoscopic partial nephrectomy in patients with localized renal parenchymal lesions depending on the nephrometric score].
Autorzy :: Sirota ES; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; FGBUN Center for Information Technologies in designing RAS, Moscow region, Moscow, Russia.
Rapoport LM; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; FGBUN Center for Information Technologies in designing RAS, Moscow region, Moscow, Russia.
Gridin VN; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; FGBUN Center for Information Technologies in designing RAS, Moscow region, Moscow, Russia.
Tsarichenko DG; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; FGBUN Center for Information Technologies in designing RAS, Moscow region, Moscow, Russia.
Kuznetsov IA; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; FGBUN Center for Information Technologies in designing RAS, Moscow region, Moscow, Russia.
Sirota AE; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; FGBUN Center for Information Technologies in designing RAS, Moscow region, Moscow, Russia.
Alyaev YG; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.; FGBUN Center for Information Technologies in designing RAS, Moscow region, Moscow, Russia.; Pokaż więcej
Źródło :: Urologiia (Moscow, Russia : 1999) [Urologiia] 2020 Dec (6), pp. 11-18.
Typ publikacji :: Journal Article
MeSH Terms :: Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Laparoscopy*
Adult ; Aged ; Humans ; Kidney/diagnostic imaging ; Kidney/surgery ; Learning Curve ; Male ; Middle Aged ; Moscow ; Nephrectomy ; Retrospective Studies ; Russia
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab.
Autorzy :: Simonaggio A; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Elaidi R; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Fournier L; Department of Radiology, Hôpital Européen Georges Pompidou, Paris, France.
Fabre E; Medical Thoracic Oncology Department, Hopital Européen Georges Pompidou, Paris, France.; U970, Université Paris Descartes Sorbonne Paris-Cité, 75006, Paris, France.
Ferrari V; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
Borchiellini D; Department of Medical Oncology, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
Thouvenin J; Department of Medical Oncology, University Hospital of Strasbourg, Strasbourg, France.
Barthelemy P; Department of Medical Oncology, University Hospital of Strasbourg, Strasbourg, France.
Thibault C; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Tartour E; Department of Immunology, Hôpital Européen Georges Pompidou, 75015, Paris, France.; U970, Université Paris Descartes Sorbonne Paris-Cité, 75006, Paris, France.
Oudard S; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France.
Vano YA; Medical Oncology Department, Hôpital Européen Georges Pompidou, Paris, France. .; INSERM, UMR-S 1138, Centre de Recherche des Cordeliers, Team 'Cancer, Immune Control and Escape', University Paris Descartes Sorbonne, 75006, Paris, France. .; Pokaż więcej
Źródło :: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2020 Dec; Vol. 69 (12), pp. 2513-2522. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Carcinoma, Non-Small-Cell Lung/*drug therapy
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Lung Neoplasms/*drug therapy
Lymphocytes/*immunology
Neutrophils/*immunology
Nivolumab/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/blood ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Renal Cell/immunology ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/secondary ; Feasibility Studies ; Female ; Humans ; Kaplan-Meier Estimate ; Kidney Neoplasms/immunology ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Leukocyte Count ; Lung Neoplasms/blood ; Lung Neoplasms/immunology ; Lung Neoplasms/mortality ; Male ; Middle Aged ; Prognosis ; Progression-Free Survival ; Prospective Studies ; Retrospective Studies ; Risk Assessment/methods ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Long intergenic non-coding RNA 1939 eliminates proliferation and migration of human renal cell carcinoma (RCC) cells by down-regulation of miR-154.
Autorzy :: Zhang R; Department of Urology, The First Affiliated Hospital of Soochow University, Jiangsu, China.
Zhang W; Department of Urology, The First Affiliated Hospital of Soochow University, Jiangsu, China.
Xu B; Department of Urology, Jining No, 1 People's Hospital, Jining, China.
Lv C; Department of Urology, Jining No, 1 People's Hospital, Jining, China.
Hou J; Department of Urology, The First Affiliated Hospital of Soochow University, Jiangsu, China.
Zhang G; Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, Jiangsu, China.; Jiangsu Key Laboratory of Clinical Immunology, Soochow University, Jiangsu, China.; Jiangsu Key Laboratory of Gastrointestinal Tumor Immunology, Jiangsu, China.; Pokaż więcej
Źródło :: Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2020 Dec; Vol. 48 (1), pp. 695-702.
Typ publikacji :: Journal Article
MeSH Terms :: Carcinoma, Renal Cell/*pathology
Cell Movement/*genetics
Cell Proliferation/*genetics
Kidney Neoplasms/*pathology
MicroRNAs/*genetics
RNA, Long Noncoding/*metabolism
Apoptosis/genetics ; Carcinoma, Renal Cell/genetics ; Carcinoma, Renal Cell/metabolism ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Humans ; Kidney Neoplasms/genetics ; Kidney Neoplasms/metabolism ; RNA, Long Noncoding/genetics ; Receptors, Notch/metabolism ; Wnt Signaling Pathway
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Prognostic Significance of the Controlling Nutritional Status (CONUT) Score in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab after Failure of Prior Tyrosine Kinase Inhibitors.
Autorzy :: Takemura K; Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.; Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Yuasa T; Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Fujiwara R; Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Ito M; Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Suzuki H; Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Yonese J; Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Koga F; Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.; Pokaż więcej
Źródło :: The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1166-1172. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :: Journal Article; Multicenter Study
MeSH Terms :: Nutrition Assessment*
Antineoplastic Agents, Immunological/*therapeutic use
Cachexia/*diagnosis
Carcinoma, Renal Cell/*therapy
Kidney Neoplasms/*therapy
Nivolumab/*therapeutic use
Aged ; Antineoplastic Agents, Immunological/pharmacology ; Cachexia/blood ; Cachexia/etiology ; Carcinoma, Renal Cell/complications ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/pathology ; Chemotherapy, Adjuvant/methods ; Cholesterol/blood ; Drug Resistance, Neoplasm ; Female ; Follow-Up Studies ; Humans ; Kidney Neoplasms/complications ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Lymphocyte Count ; Male ; Middle Aged ; Nephrectomy ; Nivolumab/pharmacology ; Nutritional Status/physiology ; Prognosis ; Progression-Free Survival ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies ; Serum Albumin, Human/analysis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Autorzy :: Gentili F; Section of Radiology, Unit of Surgical Sciences, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, University of Parma, Parma, Italy. .
Bronico I; Section of Radiology, Unit of Surgical Sciences, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, University of Parma, Parma, Italy.
Maestroni U; Department of Urology, Azienda Ospedaliero-Universitaria di Parma, University of Parma, Parma, Italy.
Ziglioli F; Department of Urology, Azienda Ospedaliero-Universitaria di Parma, University of Parma, Parma, Italy.
Silini EM; Department of Biomedical, Biotechnological and Translational Sciences, Azienda Ospedaliero-Universitaria di Parma, University of Parma, Parma, Italy.
Buti S; Section of Radiology, Unit of Surgical Sciences, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, University of Parma, Parma, Italy.; Department of Medical Oncology, Azienda Ospedaliero-Universitaria di Parma, University of Parma, Parma, Italy.
de Filippo M; Section of Radiology, Unit of Surgical Sciences, Department of Medicine and Surgery, Azienda Ospedaliero-Universitaria di Parma, University of Parma, Parma, Italy.; Pokaż więcej
Źródło :: La Radiologia medica [Radiol Med] 2020 Dec; Vol. 125 (12), pp. 1280-1287. Date of Electronic Publication: 2020 May 08.
Typ publikacji :: Journal Article
MeSH Terms :: Adenoma, Oxyphilic/*diagnostic imaging
Aorta/*diagnostic imaging
Carcinoma, Renal Cell/*diagnostic imaging
Kidney Cortex/*diagnostic imaging
Kidney Neoplasms/*diagnostic imaging
Tomography, X-Ray Computed/*methods
Adenoma, Oxyphilic/pathology ; Adult ; Aged ; Angiomyolipoma/diagnostic imaging ; Carcinoma, Papillary/diagnostic imaging ; Carcinoma, Papillary/pathology ; Carcinoma, Renal Cell/pathology ; Contrast Media ; Diagnosis, Differential ; Female ; Humans ; Kidney Neoplasms/pathology ; Leiomyoma/diagnostic imaging ; Male ; Middle Aged ; Preoperative Period ; Radiographic Image Enhancement ; Retrospective Studies ; Tumor Burden
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome: Spectrum of imaging findings.
Autorzy :: Paschall AK; National Institutes of Health Clinical Center, Radiology and Imaging Sciences, 10 Center Drive, Bethesda, MD 20814, United States of America; Duke University Health System, School of Medicine, 8 Searle Center Dr., Durham, NC 27710, United States of America.
Nikpanah M; National Institutes of Health Clinical Center, Radiology and Imaging Sciences, 10 Center Drive, Bethesda, MD 20814, United States of America.
Farhadi F; National Institutes of Health Clinical Center, Radiology and Imaging Sciences, 10 Center Drive, Bethesda, MD 20814, United States of America.
Jones EC; National Institutes of Health Clinical Center, Radiology and Imaging Sciences, 10 Center Drive, Bethesda, MD 20814, United States of America.
Wakim PG; National Institutes of Health Clinical Center, Biostatistics and Clinical Epidemiology Service, 10 Center Drive, Bethesda, MD 20814, United States of America.
Dwyer AJ; National Institutes of Health Clinical Center, Radiology and Imaging Sciences, 10 Center Drive, Bethesda, MD 20814, United States of America.
Gautam R; National Institutes of Health, National Cancer Institute- Urologic Oncology Branch, 10 Center Drive, Bethesda, MD 20814, United States of America.
Merino MJ; National Institutes of Health, National Cancer Institute- Laboratory of Pathology, 10 Center Drive, Bethesda, MD 20814, United States of America.
Srinivasan R; National Institutes of Health, National Cancer Institute- Urologic Oncology Branch, 10 Center Drive, Bethesda, MD 20814, United States of America.
Linehan WM; National Institutes of Health, National Cancer Institute- Urologic Oncology Branch, 10 Center Drive, Bethesda, MD 20814, United States of America.
Malayeri AA; National Institutes of Health Clinical Center, Radiology and Imaging Sciences, 10 Center Drive, Bethesda, MD 20814, United States of America. Electronic address: .; Pokaż więcej
Źródło :: Clinical imaging [Clin Imaging] 2020 Dec; Vol. 68, pp. 14-19. Date of Electronic Publication: 2020 Jun 09.
Typ publikacji :: Journal Article
MeSH Terms :: Carcinoma, Renal Cell*/diagnostic imaging
Carcinoma, Renal Cell*/surgery
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Leiomyomatosis*/diagnostic imaging
Leiomyomatosis*/surgery
Neoplastic Syndromes, Hereditary*/diagnostic imaging
Adult ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Re: Next-Generation RNA Sequencing-Based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms.
Autorzy :: Laguna MP; Pokaż więcej
Źródło :: The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1376. Date of Electronic Publication: 2020 Aug 21.
Typ publikacji :: Journal Article; Comment
MeSH Terms :: Adenoma, Oxyphilic*/diagnosis
Adenoma, Oxyphilic*/genetics
Carcinoma, Renal Cell*/diagnosis
Carcinoma, Renal Cell*/genetics
Kidney Neoplasms*/diagnosis
Kidney Neoplasms*/genetics
Biomarkers ; Humans ; RNA ; Sequence Analysis, RNA
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Asymptomatic chyluria presenting with fat-fluid level after renal microwave ablation.
Autorzy :: Nepal P; St. Vincent's medical center, Bridgeport, CT 06606, United States of America. Electronic address: .
Songmen S; St. Vincent's medical center, Bridgeport, CT 06606, United States of America.
Hughes T; St. Vincent's medical center, Bridgeport, CT 06606, United States of America. Electronic address: .
Batter S; Urology Associates of Norwalk, Norwalk, CT 06850, United States of America.; Pokaż więcej
Źródło :: Clinical imaging [Clin Imaging] 2020 Dec; Vol. 68, pp. 175-178. Date of Electronic Publication: 2020 Aug 13.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Carcinoma, Renal Cell*/surgery
Catheter Ablation*
Kidney Neoplasms*/diagnostic imaging
Kidney Neoplasms*/surgery
Aged ; Humans ; Kidney/surgery ; Male ; Microwaves ; Nephrectomy/adverse effects ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial.
Autorzy :: Powles T; Barts Health NHS Trust and the Royal Free NHS Foundation Trust, Barts Cancer Institute, and Queen Mary University of London, London UK. Electronic address: .
Plimack ER; Fox Chase Cancer Center, Philadelphia, PA, USA.
Soulières D; Centre Hospitalier de l'Universitaire de Montréal, Montréal, QC, Canada.
Waddell T; The Christie NHS Foundation Trust, Manchester, UK.
Stus V; Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine, Dnipro, Ukraine.
Gafanov R; Russian Scientific Center of Roentgenoradiology, Moscow, Russia.
Nosov D; Central Clinical Hospital With Outpatient Clinic, Moscow, Russia.
Pouliot F; CHU of Québec and Laval University, Québec, QC, Canada.
Melichar B; Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic.
Vynnychenko I; Sumy State University, Sumy Regional Oncology Center, Sumy Oblast, Ukraine.
Azevedo SJ; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Borchiellini D; Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
McDermott RS; Adelaide and Meath Hospital, Dublin, Ireland; University College Dublin, Dublin, Ireland.
Bedke J; University Hospital, Eberhard Karls University Tübingen, Tübingen, Germany.
Tamada S; Osaka City University Hospital, Osaka, Japan.
Yin L; Merck & Co, Kenilworth, NJ, USA.
Chen M; Merck & Co, Kenilworth, NJ, USA.
Molife LR; Merck Sharp & Dohme UK, London, UK.
Atkins MB; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
Rini BI; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Pokaż więcej
Źródło :: The Lancet. Oncology [Lancet Oncol] 2020 Dec; Vol. 21 (12), pp. 1563-1573. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :: Antibodies, Monoclonal, Humanized/*administration & dosage
Antineoplastic Agents, Immunological/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Axitinib/*administration & dosage
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Protein Kinase Inhibitors/*administration & dosage
Sunitinib/*administration & dosage
Aged ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Axitinib/adverse effects ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/pathology ; Female ; Humans ; Kidney Neoplasms/mortality ; Kidney Neoplasms/pathology ; Male ; Middle Aged ; Progression-Free Survival ; Protein Kinase Inhibitors/adverse effects ; Sunitinib/adverse effects ; Time Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Development of a Novel Scoring System Quantifies Opportunities to Reduce Surgery for Benign Renal Neoplasms: A Retrospective Quality Improvement Analysis within the MUSIC-KIDNEY Collaborative.
Autorzy :: Peabody H; Spectrum Health Hospital System, Grand Rapids, Michigan.
Patel A; Henry Ford Health System, Detroit, Michigan.
Johnson A; Michigan Medicine, Ann Arbor, Michigan.
Mirza M; Michigan Medicine, Ann Arbor, Michigan.
Noyes SL; Spectrum Health Hospital System, Grand Rapids, Michigan.
Schervish E; Michigan Institute of Urology, St. Clair Shores, Michigan.
Kaul S; Comprehensive Urology, William Beaumont Hospital, Royal Oak, Michigan.
Rogers CG; Henry Ford Health System, Detroit, Michigan.
Lane BR; Spectrum Health Hospital System, Grand Rapids, Michigan.; Michigan State University College of Human Medicine, Grand Rapids, Michigan.
Semerjian A; IHA Urology, St. Joseph Mercy Hospital, Ann Arbor, Michigan.; Pokaż więcej
Źródło :: The Journal of urology [J Urol] 2020 Dec; Vol. 204 (6), pp. 1160-1165. Date of Electronic Publication: 2020 Jul 06.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Quality Improvement*
Clinical Decision-Making/*methods
Kidney Neoplasms/*diagnosis
Medical Overuse/*prevention & control
Nephrectomy/*statistics & numerical data
Aged ; Biopsy/standards ; Humans ; Kidney/diagnostic imaging ; Kidney/pathology ; Kidney/surgery ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Neoplasm Staging ; Nephrectomy/standards ; Practice Guidelines as Topic ; Retrospective Studies ; Treatment Outcome ; Watchful Waiting/standards
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Dual role of G-quadruplex in translocation renal cell carcinoma: Exploring plausible Cancer therapeutic innovation.
Autorzy :: Neha; Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Varanasi 221005, India.
Das P; Centre for Genetic Disorders, Institute of Science, Banaras Hindu University, Varanasi 221005, India. Electronic address: .
Verma SP; Huntsman Cancer Institute, University of Utah, USA.; Pokaż więcej
Źródło :: Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2020 Dec; Vol. 1864 (12), pp. 129719. Date of Electronic Publication: 2020 Aug 31.
Typ publikacji :: Journal Article; Review
MeSH Terms :: G-Quadruplexes*
Translocation, Genetic*
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/*genetics
Carcinoma, Renal Cell/*genetics
Kidney Neoplasms/*genetics
Animals ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/therapy ; Humans ; Kidney Neoplasms/pathology ; Kidney Neoplasms/therapy ; Models, Molecular ; Oncogene Proteins, Fusion/genetics
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kidney Neoplasms"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język